rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Atea Pharmaceuticals, Inc.

AVIR · Nasdaq

Health CareBiotechnologyJust dropped out

AVIR stood above a rising 150-day average in 41 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 15.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$51K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
122 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 41 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$982K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Polly A. MurphyDirectorbought6,100at $4.1718 May 2026filed 21 May 2026
Polly A. MurphyDirectorbought6,100at $4.1718 May 2025filed 20 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders122+0 on the quarter
New · exited21 · 20
Reported value$269.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 202612,004,064$55.8M+53,292+0.4%
BlackRock, Inc.added · filed 7 Aug 20268,720,077$40.5M+284,640+3.4%
BML Capital Management, LLCreduced · filed 7 Aug 20266,952,330$32.3M-106,327−1.5%
TANG CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 20264,814,700$22.4M00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20262,964,862$13.8M-281,262−8.7%
Bain Capital Life Sciences Investors, LLCreduced · filed 14 Aug 20262,075,639$9.7M-284,999−12.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,958,435$9.1M+210,729+12.1%
STATE STREET CORPreduced · filed 7 Aug 20261,652,399$7.7M-42,236−2.5%
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 20261,506,697$7.0M-357,467−19.2%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,299,515$6.0M+44,031+3.5%
31 Mar 2023 – 30 Jun 2026
93107121Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Arthur S. Kirsch Company insiderDirector · last 18 Jun 20260 · 0
Barbara Gayle Duncan Company insiderDirector · last 18 Jun 20260 · 0
Bruce Polsky Company insiderDirector · last 18 Jun 20260 · 1
Bruno Lucidi Company insiderDirector · last 18 Jun 20260 · 0
Franklin M. Berger Company insiderDirector · last 18 Jun 20265 · 3
Howard Berman Company insiderDirector · last 18 Jun 20260 · 0
Jerome M. Adams Company insiderDirector · last 18 Jun 20260 · 0
Polly A. Murphy Company insiderDirector · last 18 Jun 20263 · 0
Andrea Corcoran Company insiderOfficer · last 11 Mar 20260 · 1
Jean-Pierre Sommadossi Company insiderPresident, CEO, and Chairman · last 3 Feb 20260 · 5
Janet M.J. Hammond Company insiderChief Development Officer · last 31 Jan 20260 · 1
John Vavricka Company insiderChief Commercial Officer · last 31 Jan 20260 · 1

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-65.7%
Share count trendFY 2025 · to 4 Mar 20262.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$95.7M

Analyst forecasts

No analyst forecasts yet.